Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Fidelity Select Biotechnology Pt: (MF: FBIOX)

(MF) As of May 4, 2016 06:05 PM ET

 Add to portfolio

$163.93 USD

-5.73 (-3.38%)

Is FBIOX a
Buy, Hold or Sell?

See its Zacks Rank in our free fund analysis report.

Get Free Report for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Mar 31, 2016

Total Return %* Percentile Rank Objective
YTD -28.45 99
3 months -28.45 99
6 months -19.28 91
1 Year -29.90 93
3 Year 14.77 55
5 Year 22.25 3
10 Year 12.41 8

* Annual for three years and beyond.

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?]
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 30.42
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 3/31/2016 9,957.96
%Turnover 3/31/2016 61.00

Risk

3 Year 5 Year 10 Year
Beta 1.37 1.20 0.86
Alpha 2.21 10.05 7.50
R Squared 0.28 0.33 0.33
Std. Dev. 29.65 25.50 22.90
Sharpe 0.67 1.03 2.00

Sector / Country Weightings

As of 3/31/2016 % of Portfolio
Health 67.97
Services 16.01
Other 14.91
Industrial Cyclical 0.92
Technology 0.14
Finance 0.05

Portfolio Holdings

Top Equity Holdings
(As of 11/30/2015)
% of Portfolio Value (Mil$)
ALEXION PHARMACEUTICALS I 4.95 747.49
GILEAD SCIENCES INC 4.62 697.87
REGENERON PHARMACEUTICALS 4.37 659.68
VERTEX PHARMACEUTICALS IN 4.33 653.40
CELGENE CORP 3.59 541.34
BIOMARIN PHARMACEUTICAL 3.24 488.53
INCYTE PHARMACEUTICALS IN 3.10 468.29
BIOGEN INC 2.98 449.47
GENMAB AS 2.14 323.05

Stock Holding % of Net Assets

As Of 11/30/2015
Total Issues 246
Avg. P/E 40.09
Avg. P/Book 5.62
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 22,939

Allocation

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 61.79
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00